• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVH

AVITA MEDICAL INC.

3.31% ! $2.92
Market Cap $200.2M  !
Healthcare Biotechnology
Add to My Watchlist

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AVH
Ann: AVH Announces New Manufacturing AGMT & Amends Distribution 		21/03/25 14 4.0K
21/03/25 Last post  Melody432 Comments Created with Sketch.  14  Views Created with Sketch.  4.0K 
AVH
Ann: Notice under section 708A(5)(e) of the Corporations Act 		20/03/25 0 247
20/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  247 
AVH
Ann: Notification regarding unquoted securities - AVH 		20/03/25 0 208
20/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  208 
AVH
AVH Chart
2
20/03/25 83 31K
20/03/25 Last post  talung66 Comments Created with Sketch.  83  Views Created with Sketch.  31K 
AVH
Ann: Change of Director's Interest Notice - Robert McNamara 		13/03/25 16 6.9K
13/03/25 Last post  BD3099 Comments Created with Sketch.  16  Views Created with Sketch.  6.9K 
AVH
Ann: Change of Director's Interest Notice - Robert McNamara 		11/03/25 11 2.4K
11/03/25 Last post  blackharry Comments Created with Sketch.  11  Views Created with Sketch.  2.4K 
AVH
Ann: AVITA Medical to Present at TD Cowen Health Care Conference 		11/03/25 18 4.9K
11/03/25 Last post  ThaLuvDocta Comments Created with Sketch.  18  Views Created with Sketch.  4.9K 
AVH
Ann: Statement of CDIs on issue - AVH 		06/03/25 0 288
06/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  288 

See All Discussions arrow Created with Sketch.

Timeline

Notice under section 708A(5)(e) of the Corporations Act
20 Mar 09:55
 
Notification regarding unquoted securities - AVH
20 Mar 09:47
 
AVH Announces New Manufacturing AGMT & Amends Distribution
18 Mar 08:19
 
Change of Director's Interest Notice - Robert McNamara
11 Mar 12:02
 
Statement of CDIs on issue - AVH
06 Mar 11:58
 
Notification of cessation of securities - AVH
05 Mar 10:43
 
View More arrow Created with Sketch.

Featured News

NEWS FDA Approves Telix’s Gozellix for New Prostate Cancer Imaging
right-arrow Created with Sketch.
NEWS HotCopper Podcast 006 – What comes first, the bear market or the election?
right-arrow Created with Sketch.
NEWS Patronus Resources Boosts Strategic Holdings with 7.73% Investment in Emmerson Resources
right-arrow Created with Sketch.
NEWS Q Precious And Battery Metals Mobilizing Diamond Drill La Corne South Project
right-arrow Created with Sketch.
NEWS Significant High-Grade Antimony-Gold Potential Identified at Heyfield Reef
right-arrow Created with Sketch.
NEWS Syntara Advances Program with New Topical Treatment for Skin Scarring
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.92 		Change
-0.100(3.31%) 		Mkt cap ! $200.2M
Open High Low Value Volume
$2.95 $2.96 $2.88 $280.8K 96.29K

Buyers (Bids)

No. Vol. Price($)
4 6608 $2.88
 

Sellers (Offers)

Price($) Vol. No.
$2.92 6415 1
View Market Depth
Last trade - 16.10pm 21/03/2025 (20 minute delay) ?
Last
$2.92 		  Change
-0.100 ( 2.34 %)
Open High Low Volume
$2.93 $2.94 $2.89 13465
Last updated 15.58pm 21/03/2025 ?
AVH (ASX) Chart

Top Stories

Expert Exchange: Are we in for another market crash?

Recent market volatility can be unnerving; HotCopper asked Andrew Baxter how to read current conditions and if there'll be a market crash.
Mt Malcolm finds economic gold averaging 3g/t at Golden Crown stockpile Mt Malcolm Mines NL has found economic grades averaging three grams per tonne from stockpiles at Golden Crown in Western Australia.
Woolworths: We're already taking steps to boost price transparency Woolworths Group Ltd has responded to a review from the ACCC on pricing transparency, saying it has already met many of the recommendations.
Kula Gold finds up to 17.9g/t of gold from old mine dumps at Mt Palmer Kula Gold Ltd has seen its share price rise significantly after reporting the presence of high-grade gold from sampling at Mt Palmer
ASX Market Close: Sentiment getting better with finish over 7,900pts Good afternoon and welcome to HotCopper’s Market Close for Thursday, I’m Jonathon Davidson.It was another better-looking day for the bourse as the XJO closed above 7,900 points.

Featured News

NEWS Significant High-Grade Antimony-Gold Potential Identified at Heyfield Reef
right-arrow Created with Sketch.
NEWS HotCopper Podcast 006 – What comes first, the bear market or the election?
right-arrow Created with Sketch.
NEWS Drilling Kicks Off at Highly Prospective Austin Gold Project in WA
right-arrow Created with Sketch.
NEWS Imugene's Azer-cel Granted FDA Fast Track Designation in Blood Cancer
right-arrow Created with Sketch.
NEWS FDA Approves Telix’s Gozellix for New Prostate Cancer Imaging
right-arrow Created with Sketch.
NEWS Maiden Gold Pour at Laverton Mill Completed as Brightstar’s CY25 Production and Revenue Ramp-Up
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.